| 000 | 01456 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513191316.0 | ||
| 264 | 0 | _c19991026 | |
| 008 | 199910s 0 0 eng d | ||
| 022 | _a0163-7258 | ||
| 024 | 7 |
_a10.1016/s0163-7258(98)00048-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarquez, V E | |
| 245 | 0 | 0 |
_aThe transition from a pharmacophore-guided approach to a receptor-guided approach in the design of potent protein kinase C ligands. _h[electronic resource] |
| 260 |
_bPharmacology & therapeutics _c |
||
| 300 |
_a251-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIsoenzymes _xchemistry |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPharmacology _xtrends |
| 650 | 0 | 4 |
_aProtein Kinase C _xmetabolism |
| 650 | 0 | 4 |
_aProtein Kinases _xmetabolism |
| 700 | 1 | _aNacro, K | |
| 700 | 1 | _aBenzaria, S | |
| 700 | 1 | _aLee, J | |
| 700 | 1 | _aSharma, R | |
| 700 | 1 | _aTeng, K | |
| 700 | 1 | _aMilne, G W | |
| 700 | 1 | _aBienfait, B | |
| 700 | 1 | _aWang, S | |
| 700 | 1 | _aLewin, N E | |
| 700 | 1 | _aBlumberg, P M | |
| 773 | 0 |
_tPharmacology & therapeutics _gvol. 82 _gno. 2-3 _gp. 251-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0163-7258(98)00048-5 _zAvailable from publisher's website |
| 999 |
_c10411884 _d10411884 |
||